The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalvern Intl Regulatory News (MLVN)

Share Price Information for Malvern Intl (MLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.00
Bid: 19.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 2.00 (10.526%)
Open: 20.00
High: 20.00
Low: 20.00
Prev. Close: 20.00
MLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Nov 2021 07:00

RNS Number : 9380T
Malvern International PLC
30 November 2021
 

30 November 2021

 

 

MALVERN INTERNATIONAL PLC

("Malvern" or the "Company")

 

 

Directorate Change

 

Malvern International plc (AIM: MLVN), the global learning and skills development partner, is pleased to announce the appointment of Daniel Ian Fisher as a director of the Company with immediate effect. Mr Fisher has worked as the Company's head of finance since January 2021.

Daniel has held a number of financial leadership roles through his career including European Financial Controller of Newell Brands plc, Group Financial Controller of QANTM Intellectual Property Ltd and Head of Finance / Financial Controller of FPA Patent Attorneys Pty.

Mark Elliott, Non-Executive Chairman, commented:

"We are delighted that Daniel has agreed to step up to the role of CFO at Malvern. Daniel has served as Financial Director since January 2020 and has already proven the value and experience he brings through his contribution over the last 11 months."

In accordance with Schedule 2(g) of the AIM Rules, Daniel Ian Fisher, aged 37, holds or has held in the past five years the following directorships and partnerships:

Current Directorships

Directorships within last 5 years

Malvern House International Ltd

None

Communicate English School Ltd

 

Malvern House Group Ltd

 

 

There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

 

For further information please contact:

 

Malvern International Plc

Richard Mace - Chief Executive Officer

www.malverninternational.com

Via Communications Portfolio

 

 

NOMAD and Broker

WH Ireland Limited

Mike Coe / Sarah Mather

www.whirelandcb.com

 

+44 20 7220 1666

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLBDBBUDDGBC
Date   Source Headline
23rd Apr 20247:00 amRNSAnnual Report & Notice of AGM
10th Apr 20247:00 amRNSFinal Results
4th Mar 202412:00 pmRNSIssue of Warrants
14th Feb 202411:02 amRNSCorrection: Trading Update
15th Jan 20245:22 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSContract extension
15th Nov 20237:00 amRNSAppointment of CDO & Grant of EMI Options
3rd Oct 20237:00 amRNSClosure of Malvern House, Brighton
29th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSTrading Update
30th May 202312:37 pmRNSResult of AGM
30th May 20237:00 amRNSTrading Update
15th May 20237:00 amRNSPartnership Agreement
26th Apr 20237:00 amRNSAnnual Report & Notice of Annual General Meeting
12th Apr 20234:23 pmRNSDirector Dealing
12th Apr 20237:00 amRNSDirector Dealing
6th Apr 20237:00 amRNSFinal Results
3rd Apr 202310:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSTrading Update
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20234:40 pmRNSSecond Price Monitoring Extn
19th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Nov 20224:11 pmRNSGrant of Options
10th Nov 20221:48 pmRNSDirectors Dealing
10th Nov 202210:36 amRNSHolding(s) in Company
10th Nov 202210:31 amRNSDirectors Dealing
10th Nov 20227:00 amRNSPlacing and Total Voting Rights
2nd Nov 20223:31 pmRNSCorrection: Result of General Meeting and TVR
2nd Nov 202211:44 amRNSResult of General Meeting and Total Voting Rights
2nd Nov 20227:00 amRNSTrading Update
17th Oct 20227:00 amRNSShare Reorganisation an Notice of General Meeting
17th Oct 20227:00 amRNSShare Reorganisation and Notice of General Meeting
4th Oct 20224:24 pmRNSHolding(s) in Company
29th Sep 20228:23 amRNSHolding(s) in Company
27th Sep 20228:25 amRNSDirector dealings
22nd Sep 20228:42 amRNSDirector dealings
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSHalf-year Report
25th Aug 20227:00 amRNSTrading update
9th Aug 20225:11 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSLoan Conversion and Issue of Equity
8th Jun 202211:33 amRNSResult of AGM & Director Disclosure
23rd May 20227:00 amRNSContract award
4th May 20227:00 amRNSFinal Results
4th Mar 20227:00 amRNSDebt restructuring
4th Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.